Skip to main content
. 2012 Jun;26(6):353–357. doi: 10.1155/2012/725468

TABLE 1.

Evaluated treatments for nonalcoholic fatty liver disease

Lifestyle intervention
  Calorie restriction
  Exercise
Pharmacological therapy
  Insulin sensitizers: metformin, thiazolidinediones, incretin-based therapies
  Lipid-lowering agents: statins, fibrates, PUFA
  Cytoprotective and antioxidant agents: URSO, Vitamin E, silymarin, betaine
  Anti-TNF-α agents: Pentoxifylline, monoclonal antibodies
Phlebotomy
Surgical intervention and antiobesity drugs
  Bariatric surgery
  Orlistat

PUFA N-3 polyunsaturated fatty acids; TNF Tumour necrosis factor; URSO Ursodeoxycholic acid